US Broker Ratings

Axsome Therapeutics (AXSM) Stock Analysis: Unpacking the 16.68% Upside Potential and Robust Revenue Growth

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is a biopharmaceutical company making significant strides in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $8.94 billion, Axsome is..

Glaukos Corporation (GKOS) Stock Analysis: A Growing Titan in the Healthcare Sector with a 5.88% Upside

Glaukos Corporation (NYSE: GKOS), a leader in the healthcare sector specializing in ophthalmic pharmaceuticals and medical technology, is capturing investor attention with its robust growth trajectory. With a market cap..

Alkermes plc (ALKS)

⚠️ No article content returned.

..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Navigating the Biotech Volatility with a 41.80 RSI Signal

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) is a compelling player in the healthcare sector, specializing in biotechnology with a focus on genetic therapies for rare diseases. With a market capitalization of..

Genmab A/S (GMAB) Stock Analysis: Unveiling a 17% Upside Potential in the Biotechnology Space

Genmab A/S (NASDAQ: GMAB), a prominent player in the biotechnology sector, is capturing investor attention with its promising portfolio and a substantial potential upside of 17.25%. As a Danish-based company..

Exact Sciences Corporation (EXAS) Stock Analysis: A Healthcare Innovator Nearing Its 52-Week High

Exact Sciences Corporation (NASDAQ: EXAS), a leader in the healthcare diagnostics and research sector, has been making waves with its innovative cancer screening and diagnostic products. As the company reaches..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Unlocking a 13.68% Potential Upside in the Healthcare Sector

Intuitive Surgical, Inc. (ISRG), a titan in the healthcare sector, continues to capture investor attention with its innovative medical instruments and a robust market presence in the minimally invasive surgical..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Navigating Growth and Value in the Healthcare Sector

Thermo Fisher Scientific Inc (NYSE: TMO) has solidified its position as a titan in the healthcare sector, specializing in diagnostics and research. With a market capitalization of $232.46 billion, the..

RadNet, Inc. (RDNT) Stock Analysis: Potential 29% Upside Beckons Investors

RadNet, Inc. (NASDAQ: RDNT), a healthcare sector leader specializing in diagnostic imaging, has captured investor attention with its robust growth potential. With a current market capitalization of $5.49 billion, RadNet..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Uncovering a 38% Potential Upside with Strong Buy Ratings

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is an intriguing player in the biotechnology sector, capturing investor attention with its focus on rare neuroendocrine diseases. With a market capitalization of $6.78 billion..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Insight into a Healthcare Giant with a Global Reach

Bausch + Lomb Corporation (NYSE: BLCO) is a notable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a rich history dating back to 1853,..

Nuvalent, Inc. (NUVL) Stock Analysis: Unpacking the 35.92% Potential Upside for Biotech Investors

Nuvalent, Inc. (NASDAQ: NUVL) is an exciting player in the biotechnology sector, drawing attention with a market capitalization of $8.1 billion. Headquartered in Cambridge, Massachusetts, Nuvalent is a clinical-stage biopharmaceutical..

Oscar Health (OSCR) Stock Analysis: Navigating the Healthcare Sector with a 23.20% Revenue Growth

Oscar Health, Inc. (NYSE: OSCR) stands as a dynamic player in the healthcare plans industry, offering innovative solutions to a broad range of clients. Headquartered in New York and operating..

BeOne Medicines Ltd. (ONC)

⚠️ No article content returned.

..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating Growth with a Robust 23.7% Revenue Surge

Medpace Holdings, Inc. (NASDAQ: MEDP), a formidable player in the healthcare sector, has recently captured investor attention with its impressive 23.7% revenue growth. Specializing in diagnostics and research, Medpace offers..

Globus Medical, Inc. (GMED) Stock Analysis: Navigating a 13.83% Potential Upside with Innovative Medical Solutions

Globus Medical, Inc. (NYSE: GMED), a renowned player in the healthcare sector, particularly in the medical devices industry, presents a compelling opportunity for investors seeking growth in a rapidly evolving..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Uncovering a Potential 46.74% Upside in the Biotech Arena

TG Therapeutics, Inc. (NASDAQ: TGTX) stands out in the biotechnology sector, capturing the attention of investors with its innovative approach to tackling B-cell mediated diseases. With a robust market cap..

Revolution Medicines (RVMD) Stock Analysis: Navigating the RAS-Driven Cancer Market with a $23.25 Billion Valuation

Revolution Medicines, Inc. (NASDAQ: RVMD) is making waves in the biotechnology sector with its innovative approach to combat RAS-driven cancers. As a clinical-stage precision oncology company, Revolution Medicines is focused..

Royalty Pharma plc (RPRX) Stock Analysis: Navigating Substantial Upside Potential with a 17.95% Forecasted Increase

Royalty Pharma plc (NASDAQ: RPRX) stands out as a unique player in the biotechnology sector, with a business model that revolves around acquiring biopharmaceutical royalties and funding innovation. Based in..

AptarGroup, Inc. (ATR) Stock Report: Exploring a 27.61% Upside with Strong Analyst Ratings

AptarGroup, Inc. (NYSE: ATR), a formidable player in the medical instruments and supplies industry, is garnering investor attention with a promising 27.61% potential upside, as indicated by its average analyst..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds